{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:12:29Z","timestamp":1791479549456,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03214-5","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T15:05:42Z","timestamp":1665673542000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patient reported outcomes and treatment satisfaction in patients with cushing syndrome"],"prefix":"10.1007","volume":"79","author":[{"given":"Maureen","family":"Rakovec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham M.","family":"Khalafallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Hamrahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Gallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Nyall R.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Murugappan","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-8237","authenticated-orcid":false,"given":"Debraj","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"3214_CR1","doi-asserted-by":"publisher","unstructured":"C. Steffensen, A.M. Bak, K. Z\u00f8ylner Rubeck, J.O.L. J\u00f8rgensen, Epidemiology of Cushing\u2019s syndrome. Neuroendocrinology 92, 1\u20135 (2010). https:\/\/doi.org\/10.1159\/000314297","DOI":"10.1159\/000314297"},{"issue":"11","key":"3214_CR2","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3390\/jcm8111951","volume":"8","author":"H Nishioka","year":"2019","unstructured":"H. Nishioka, S. Yamada, Cushing\u2019s disease. J. Clin. Med. 8(11), 1951 (2019). https:\/\/doi.org\/10.3390\/jcm8111951","journal-title":"J. Clin. Med."},{"key":"3214_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/CLEP.S44336","volume":"7","author":"ST Sharma","year":"2015","unstructured":"S.T. Sharma, L.K. Nieman, R.A. Feelders, Cushing\u2019s syndrome: epidemiology and developments in disease management. Clin. Epidemiol. 7, 281\u2013293 (2015). https:\/\/doi.org\/10.2147\/CLEP.S44336","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"3214_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3171\/2016.1.JNS152119","volume":"126","author":"RR Lonser","year":"2017","unstructured":"R.R. Lonser, L. Nieman, E.H. Oldfield, Cushing\u2019s disease: pathobiology, diagnosis, and management. J. Neurosurg. 126(2), 404\u2013417 (2017). https:\/\/doi.org\/10.3171\/2016.1.JNS152119","journal-title":"J. Neurosurg."},{"issue":"2","key":"3214_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cen.14014","volume":"91","author":"S Wengander","year":"2019","unstructured":"S. Wengander, P. Trimpou, E. Papakokkinou, O. Ragnarsson, The incidence of endogenous Cushing\u2019s syndrome in the modern era. Clin. Endocrinol. (Oxf.) 91(2), 263\u2013270 (2019). https:\/\/doi.org\/10.1111\/cen.14014","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"3214_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","volume":"56","author":"R Pivonello","year":"2017","unstructured":"R. Pivonello, M.C. De Martino, M. De Leo, C. Simeoli, A. Colao, Cushing\u2019s disease: the burden of illness. Endocrine 56(1), 10\u201318 (2017). https:\/\/doi.org\/10.1007\/s12020-016-0984-8","journal-title":"Endocrine"},{"issue":"4","key":"3214_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"R. Pivonello, M. De Leo, A. Cozzolino, A. Colao, The treatment of Cushing\u2019s disease. Endocr. Rev. 36(4), 385\u2013486 (2015). https:\/\/doi.org\/10.1210\/er.2013-1048","journal-title":"Endocr. Rev."},{"issue":"Suppl 1","key":"3214_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000314317","volume":"92","author":"AM Pereira","year":"2010","unstructured":"A.M. Pereira, J. Tiemensma, J.A. Romijn, Neuropsychiatric disorders in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1), 65\u201370 (2010). https:\/\/doi.org\/10.1159\/000314317","journal-title":"Neuroendocrinology"},{"issue":"2","key":"3214_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","volume":"141","author":"MN Starkman","year":"1981","unstructured":"M.N. Starkman, D.E. Schteingart, Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Arch. Intern Med. 141(2), 215\u2013219 (1981)","journal-title":"Arch. Intern Med."},{"issue":"7","key":"3214_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"R. Pivonello, A.M. Isidori, M.C. De Martino, J. Newell-Price, B.M.K. Biller, A. Colao, Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol. 4(7), 611\u2013629 (2016). https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"3214_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"J.R. Lindsay, T. Nansel, S. Baid, J. Gumowski, L.K. Nieman, Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J. Clin. Endocrinol. Metab. 91(2), 447\u2013453 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1058","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3214_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0958-4","volume":"13","author":"N Knoble","year":"2018","unstructured":"N. Knoble, G. Nayroles, C. Cheng, B. Arnould, Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing\u2019s syndrome. Orphanet J. Rare Dis. 13(1), 228 (2018). https:\/\/doi.org\/10.1186\/s13023-018-0958-4","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"3214_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.17925\/EE.2015.11.01.34","volume":"11","author":"I Huguet","year":"2015","unstructured":"I. Huguet, G. Ntali, A. Grossman, N. Karavitaki, Cushing\u2019s disease - quality of life, recurrence and long-term morbidity. Eur. Endocrinol. 11(1), 34\u201338 (2015). https:\/\/doi.org\/10.17925\/EE.2015.11.01.34","journal-title":"Eur. Endocrinol."},{"issue":"5","key":"3214_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"S.M. Webb, X. Badia, M.J. Barahona et al. Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur. J. Endocrinol. 158(5), 623\u2013630 (2008). https:\/\/doi.org\/10.1530\/EJE-07-0762","journal-title":"Eur. J. Endocrinol."},{"key":"3214_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fendo.2019.00862","volume":"10","author":"A Santos","year":"2019","unstructured":"A. Santos, E. Resmini, M.A. Mart\u00ednez Mombl\u00e1n, E. Valassi, L. Martel, S.M. Webb, Quality of life in patients with Cushing\u2019s disease. Front Endocrinol. (Lausanne) 10, 862 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00862","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"6","key":"3214_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2265.2011.04191.x","volume":"76","author":"M Milian","year":"2012","unstructured":"M. Milian, P. Teufel, J. Honegger, B. Gallwitz, G. Schnauder, T. Psaras, The development of the Tuebingen Cushing\u2019s disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties. Clin. Endocrinol. (Oxf.) 76(6), 851\u2013860 (2012). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04191.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"3214_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","volume":"76","author":"M Milian","year":"2012","unstructured":"M. Milian, P. Teufel, J. Honegger, B. Gallwitz, G. Schnauder, T. Psaras, The development of the Tuebingen Cushing\u2019s disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people. Clin. Endocrinol. (Oxf.) 76(6), 861\u2013867 (2012). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04280.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"3214_CR18","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO van Aken","year":"2005","unstructured":"M.O. van Aken, A.M. Pereira, N.R. Biermasz et al. Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 90(6), 3279\u20133286 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1375","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3214_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","volume":"23","author":"P Gotch","year":"1994","unstructured":"P. Gotch, Cushing\u2019s syndrome from the patient\u2019s perspective. Endocrinol. Metab. Clin. N. Am. 23, 607\u2013617 (1994)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"3","key":"3214_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"E. Valassi, A. Santos, M. Yaneva et al. The European Registry on Cushing\u2019s syndrome: 2-Year experience. Baseline demographic and clinical characteristics. Eur. J. Endocrinol. 165(3), 383\u2013392 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0272","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"3214_CR21","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2020.3.FOCUS2044","volume":"48","author":"MD Cusimano","year":"2020","unstructured":"M.D. Cusimano, T.Q. Huang, A. Marchie, H.S. Smyth, K. Kovacs, Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing\u2019s disease. Neurosurg. Focus 48(6), E4 (2020). https:\/\/doi.org\/10.3171\/2020.3.FOCUS2044","journal-title":"Neurosurg. Focus"},{"issue":"9","key":"3214_CR22","doi-asserted-by":"publisher","first-page":"e3959","DOI":"10.1210\/clinem\/dgac269","volume":"107","author":"SM Webb","year":"2022","unstructured":"S.M. Webb, E. Valassi, Consequences of Cushing\u2019s syndrome: health versus personal costs. J. Clin. Endocrinol. Metab. 107(9), e3959\u2013e3960 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac269","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3214_CR23","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.beem.2021.101505","volume":"35","author":"MM Bride","year":"2021","unstructured":"M.M. Bride, I. Crespo, S.M. Webb, E. Valassi, Quality of life in Cushing\u2019s syndrome. Best. Pr. Res Clin. Endocrinol. Metab. 35(1), 101505 (2021). https:\/\/doi.org\/10.1016\/j.beem.2021.101505","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"3214_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/bjp.bp.107.040113","volume":"192","author":"M Nock","year":"2008","unstructured":"M. Nock, G. Borges, E. Bromet et al. Cross-national prevalence and risk factors for suicidal ideation, plans, and attempts. Br. J. Psychiatry 192, 98\u2013105 (2008)","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"3214_CR25","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"O. Ragnarsson, D.S. Olsson, E. Papakokkinou et al. Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study. J. Clin. Endocrinol. Metab. 104(6), 2375\u20132384 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02524","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10024","key":"3214_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0140-6736(15)00234-2","volume":"387","author":"G Turecki","year":"2016","unstructured":"G. Turecki, D.A. Brent, Suicide and suicidal behaviour. Lancet 387(10024), 1227\u20131239 (2016). https:\/\/doi.org\/10.1016\/S0140-6736(15)00234-2","journal-title":"Lancet"},{"issue":"1-3","key":"3214_CR27","first-page":"30","volume":"17","author":"TY Lin","year":"2020","unstructured":"T.Y. Lin, J. Hanna, W.W. Ishak, Psychiatric symptoms in cushing\u2019s syndrome: a systematic review. Innov. Clin. Neurosci. 17(1-3), 30\u201335 (2020)","journal-title":"Innov. Clin. Neurosci."},{"key":"3214_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2015.00129","volume":"9","author":"R Pivonello","year":"2015","unstructured":"R. Pivonello, C. Simeoli, M.C. De Martino, A. Cozzolino, M. De Leo, D. Iacuaniello, C. Pivonello, M. Negri, M.T. Pellecchia, F. Iasevoli, A. Colao, Neuropsychiatric disorders in Cushing\u2019s syndrome. Front Neurosci. 9, 129 (2015). https:\/\/doi.org\/10.3389\/fnins.2015.00129","journal-title":"Front Neurosci."},{"issue":"5","key":"3214_CR29","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-16-0946","volume":"176","author":"JW Findling","year":"2017","unstructured":"J.W. Findling, H. Raff, Differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome). Eur. J. Endocrinol. 176(5), R205\u2013R216 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0946","journal-title":"Eur. J. Endocrinol."},{"key":"3214_CR30","doi-asserted-by":"publisher","unstructured":"G. Rubinstein, A. Osswald, E. Hoster, et al. Time to diagnosis in Cushing\u2019s syndrome: a meta-analysis based on 5367 patients. J. Clin. Endocrinol. Metab. 2020;105(3). https:\/\/doi.org\/10.1210\/clinem\/dgz136","DOI":"10.1210\/clinem\/dgz136"},{"issue":"3","key":"3214_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/cen.12521","volume":"82","author":"A Carluccio","year":"2015","unstructured":"A. Carluccio, N.K. Sundaram, S. Chablani et al. Predictors of quality of life in 102 patients with treated Cushing\u2019s disease. Clin. Endocrinol. (Oxf.) 82(3), 404\u2013411 (2015). https:\/\/doi.org\/10.1111\/cen.12521","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"3214_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-12-0308","volume":"167","author":"MAEM Wagenmakers","year":"2012","unstructured":"M.A.E.M. Wagenmakers, R.T. Netea-Maier, J.B. Prins, T. Dekkers, M. Den Heijer, A.R.M.M. Hermus, Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism. Eur. J. Endocrinol. 167(5), 687\u2013695 (2012). https:\/\/doi.org\/10.1530\/EJE-12-0308","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"3214_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/EJE-12-0325","volume":"167","author":"A Santos","year":"2012","unstructured":"A. Santos, E. Resmini, M.A. Mart\u00ednez-Mombl\u00e1n et al. Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice. Eur. J. Endocrinol. 167(3), 337\u2013342 (2012). https:\/\/doi.org\/10.1530\/EJE-12-0325","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:35:54Z","timestamp":1672853754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03214-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N. London receives research funding from Merck not related to this study. N. London holds stock in Navigen Pharmaceuticals and was a consultant for Cooltech Inc., neither are related to this study. On behalf of all other authors, the corresponding author states no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed by and received Institutional Review Board approval (IRB00215471).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants who completed the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}